Skip to main content
letter
. 2024 Jun 18;30(4):965–969. doi: 10.3350/cmh.2024.0386

Figure 1.

Figure 1.

(A) Etiology distribution of HCC. (B) Proportion of MAFLD in different subgroups during 2018–2023. (C) Proportions of MAFLD in HBV, HCV, and ALD-related HCC. (D) Proportions of single-MAFLD, mixed-MAFLD and total-MAFLD in HCC. MAFLD, metabolic dysfunction-associated fatty liver disease; HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus; ALD, alcohol-related liver disease.